Diabetic Kidney Disease Clinical Trials

16 recruiting

Frequently Asked Questions

Common questions about Diabetic Kidney Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 117 of 17 trials

Recruiting
Not Applicable

Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care

Chronic Kidney DiseaseType 2 DiabetesDiabetic Kidney Disease
Nova Scotia Health Authority120 enrolled1 locationNCT07169422
Recruiting
Phase 2

Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease

Diabetic Kidney Disease (DKD)
Regeneron Pharmaceuticals270 enrolled29 locationsNCT07271186
Recruiting

Family Investigation of Nephropathy and Diabetes (F.I.N.D.)

Diabetes MellitusAlbuminuriaDiabetic Kidney Disease+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)100,000 enrolled1 locationNCT00342927
Recruiting
Phase 2

NAD Augmentation in Diabetes Kidney Disease

Type2diabetesDiabetic Kidney Disease
Brigham and Women's Hospital140 enrolled1 locationNCT05759468
Recruiting

Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors

Chronic Kidney DiseasesMolecular Sequence VariationAlbuminuria+4 more
Herlev Hospital300 enrolled13 locationsNCT04916132
Recruiting
Phase 2

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

Type 1 DiabetesDiabetic Kidney Disease
University of Washington60 enrolled4 locationsNCT05822609
Recruiting
Phase 2

Renal Mechanism of SGLT2 Inhibition

Type 2 DiabetesDiabetic Kidney Disease
University of Colorado, Denver40 enrolled2 locationsNCT05507892
Recruiting
Phase 1

MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes

Cardiovascular DiseasesEndothelial DysfunctionType 1 Diabetes+2 more
Kalie Tommerdahl60 enrolled2 locationsNCT05065372
Recruiting

A Long-Term Follow-Up Study of Participants Exposed to REACT

Chronic Kidney DiseasesDiabetic Kidney Disease
Prokidney80 enrolled1 locationNCT05918523
Recruiting
Not Applicable

Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community

Cardiovascular ComplicationType 2 DiabetesDiabetic Kidney Disease
Shanghai Zhongshan Hospital5,600 enrolled13 locationsNCT05349955
Recruiting

Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)

PubertyType 2 Diabetes MellitusDiabetic Kidney Disease+3 more
Petter Bjornstad100 enrolled2 locationsNCT05008276
Recruiting
Phase 4

Mechanism of SGLT2 Inhibition in the Kidney

Type 2 DiabetesDiabetic Kidney Disease
University of Michigan20 enrolled1 locationNCT06291155
Recruiting

Real World Evidence Clinical Utility Study of KidneyIntelX

Chronic Kidney DiseasesDiabetic Kidney Disease
Renalytix AI, Inc.10,000 enrolled1 locationNCT04802395
Recruiting

Decision Impact Trial of KidneyIntelX

Diabetic Kidney Disease
Renalytix AI, Inc.1,500 enrolled1 locationNCT04791358
Recruiting

Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study)

Type 1 DiabetesDiabetic Kidney DiseaseDiabetic Nephropathies+2 more
University of Colorado, Denver100 enrolled1 locationNCT05319990
Recruiting

Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Nephropathy

Type 2 DiabetesDiabetic Kidney DiseaseDiabetic Nephropathy Type 2
Chinese PLA General Hospital2,000 enrolled1 locationNCT05888909
Recruiting

Correlation Study Between Clinical Phenotype and Pathology of Type 2 Diabetic Nephropathy

Diabetic Kidney Disease
Chinese PLA General Hospital2,000 enrolled1 locationNCT03865914